Citigroup’s Loxo Oncology, Inc LOXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-100
Closed -$14K 7970
2018
Q4
$14K Buy
+100
New +$15.2K ﹤0.01% 7050

Other funds holding LOXO

Citigroup's LOXO Position: Q1 2019 in Review

Citigroup sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 54,619 shares — an estimated $7.65M sold.

Citigroup first reported a position in LOXO in Q3 2014 and held it in 18 quarters. The position peaked at $7.65M in Q4 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • Citigroup reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • Citigroup sold 54,619 Loxo Oncology, Inc shares in Q1 2019, an estimated $7.65M.
  • Citigroup first reported a position in Loxo Oncology, Inc in Q3 2014 and held it in 18 quarters.
  • Citigroup's Loxo Oncology, Inc position peaked at $7.65M in Q4 2018.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Citigroup's 13F filing for Q1 2019, filed 13 May 2019.